Safe Implant Technology ApS: Financial statements 2019
CVR: 38969153
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Safe Implant Technology ApS (CVR 38969153) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -3,125 and a net result of DKK -3,125. Equity in the 2019 report amounted to DKK 43,750. The solvency ratio was 11.1%.
- Gross Profit
- DKK -3,125
- Profit/Loss
- DKK -3,125
- Equity
- DKK 43,750
- Total Assets
- DKK 392,975
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Safe Implant Technology ApS has published its interim report for the period September 25, 2017 – December 31, 2018.
About Safe Implant Technology ApS
Safe Implant Technology ApS is a Danish company of the type Anpartsselskab based in Fårevejle, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Nakskov. The board consists of Søren Luplau-Pagh (chair), Gorm Danscher, Henrik Nakskov and Lone Damgaard Horup. The company is owned by BERLOCK ApS and Devopharma ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 756,423 and a net result of DKK -53,855 compared with DKK -724,511 the year before. Equity in the 2025 report amounted to DKK -946,258.